Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ disodium

Cat. No.: HY-W013175S2 Purity: ≥99.0%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ (disodium) is the ¹³C and ¹⁵N labeled Uridine 5'-monophosphate disodium salt[1]. Uridine 5'-monophosphate disodium salt is component used for RNA synthesis[2].

For research use only. We do not sell to patients.

Uridine 5'-monophosphate-<sup>13</sup>C<sub>9</sub>,<sup>15</sup>N<sub>2</sub> disodium Chemical Structure

Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ disodium Chemical Structure

Size	Price	Stock	Quantity
Solvent
1 mg（100 mM in 26.38 μL Tris HCl/H2O buffer）	USD 240	In-stock	Estimated Time of Arrival: December 31

Synthetic products have potential research and development risk.

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ disodium:

Uridine 5'-monophosphate disodium salt In-stock

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ (disodium) is the ¹³C and ¹⁵N labeled Uridine 5'-monophosphate disodium salt[1]. Uridine 5'-monophosphate disodium salt is component used for RNA synthesis[2].
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ disodium Related Antibodies
Molecular Weight	379.07
Formula	¹³C₉H₁₁¹⁵N₂Na₂O₉P
Appearance	Liquid
Color	Colorless to light yellow
SMILES	O=[13C]([13CH]=[13CH][15N]1[13C@@]2([H])[13C@@]([13C@@]([13C@](O2)([13CH2]OP(O[Na])(O[Na])=O)[H])(O)[H])(O)[H])[15NH][13C]1=O
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Solution, -20°C, 2 years
Purity & Documentation	Purity: ≥99.0% Select Batch: Data Sheet (273 KB) SDS (251 KB) COA (257 KB) Handling Instructions (2659 KB)
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief] [2]. Hozumi Y, et al. Orotate phosphoribosyltransferase localizes to the Golgi complex and its expression levels affect the sensitivity to anti-cancer drug 5-fluorouracil. Biomed Res. 2015;36(6):403-9. [Content Brief]